345964-72-9

Basic information

• Product Name: N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide
• Synonyms: N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide
• CAS NO: 345964-72-9
• Molecular Weight: 268.153
• Mol File: 345964-72-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide(345964-72-9)
• EPA Substance Registry System: N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide(345964-72-9)

Safety Data

• Hazardous Substances Data: 345964-72-9(Hazardous Substances Data)

Upstream product

• 3350-78-5 3,3-Dimethylacryloyl chloride 
• 6911-87-1 4-bromo-N-methylaniline 

Downstream Products

• 144583-92-6 6-bromo-1,4,4-trimethyl-2-oxo-1,2,3,4-tetrahydroquinoline 

Relevant articles and documents

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having Formula 2 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having Formula 8 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Novel compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification, and certain previously known compounds have been discovered to act as inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. The compound can also be used in co-treatment with retinoids.